click below
click below
Normal Size Small Size show me how
Pharm Unit 12
SPC Pharmacology Unit 12 Exam 4
| Question | Answer |
|---|---|
| Antihistimines | *Acts as H1 receptor antagonist, *reduces allergic response, may cause sleepiness and reduce edema, spasm, itch, runny nose |
| Non-Steroid Anti-Inflammatory Agents are used? | to prevent degranualization of mast cells |
| 3 Non-Steroid Anti-Inflammatory Agents are? | Tilade, Intal, Zaditen |
| Tilade | Mast Cell Stabilizer 2-4 days noted improvement |
| Intal | Mast Cell Stabilizer May take weeks Immediate noted improvement |
| Zaditen | Mast Cell Stabilizer |
| 3 Mast Cell Stabilizer | Tilade, Intal, Zaditen |
| Intal Applications | DPI 20mg MDI QID 2puffs 1mg/puff Nebulizer QID 20mg in 2ml purified water |
| IgE antibody | is known to promote asthma and its production is dependent on interlukin-4 |
| IgE reaction chain | promotes anibody synthesis binds to mast cells makes mast cell sensitive to antigen IgE # increase and bridge to each other |
| Leukotrienes | Produced by eosinophiles and other cells cause airway edema promote bronchospasm and inflammation increase mucus production |
| Accolate | LT receptor antagonist PO (by mouth) 20mg BID (twice a day) |
| Accolate Side-effects | Nausea Diarrhea Pulmonary Infections |
| Singulair | LT Receptor Antagonist tablets/granuals children >1 year |
| Zyflo | 5-lipoxygenase acts to interrupt synthesis of LT's PO (by mouth) 600mg QID (4 times a day) |
| Zyflo Side-effects | liver toxicity abdominal pain increases theophylline serum levels, needs reduced dose by 50% |
| Xolair | Antagonist- binds to and limit degranulization of mast cells maintenance drug for moderate to severe asthma |
| Xolair Adverse-Effects | viral infections upper respiratory tract infection headache pharyngitis |